These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8778209)

  • 21. Targeting T cell costimulation in autoimmune disease.
    Stuart RW; Racke MK
    Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.
    Gause WC; Urban JF; Linsley P; Lu P
    Immunol Res; 1995; 14(3):176-88. PubMed ID: 8778208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses.
    Blazevic V; Trubey CM; Shearer GM
    J Clin Immunol; 2001 Jul; 21(4):293-302. PubMed ID: 11506200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD28/CTLA-4 and CD80/CD86 families: signaling and function.
    Slavik JM; Hutchcroft JE; Bierer BE
    Immunol Res; 1999; 19(1):1-24. PubMed ID: 10374692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B7-mediated costimulation and the immune response.
    Schultze J; Nadler LM; Gribben JG
    Blood Rev; 1996 Jun; 10(2):111-27. PubMed ID: 8813343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
    Freeman GJ; Gribben JG; Boussiotis VA; Ng JW; Restivo VA; Lombard LA; Gray GS; Nadler LM
    Science; 1993 Nov; 262(5135):909-11. PubMed ID: 7694363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
    J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD28/B7 costimulation: a review.
    Greenfield EA; Nguyen KA; Kuchroo VK
    Crit Rev Immunol; 1998; 18(5):389-418. PubMed ID: 9784967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease.
    Karandikar NJ; Vanderlugt CL; Bluestone JA; Miller SD
    J Neuroimmunol; 1998 Aug; 89(1-2):10-8. PubMed ID: 9726820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complexity of the B7-CD28/CTLA-4 costimulatory pathway.
    Schweitzer AN; Sharpe AH
    Agents Actions Suppl; 1998; 49():33-43. PubMed ID: 9426826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
    J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia.
    LaBelle JL; Hanke CA; Blazar BR; Truitt RL
    Blood; 2002 Mar; 99(6):2146-53. PubMed ID: 11877291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of experimental autoimmune encephalomyelitis using peptide mimics of CD28.
    Srinivasan M; Gienapp IE; Stuckman SS; Rogers CJ; Jewell SD; Kaumaya PT; Whitacre CC
    J Immunol; 2002 Aug; 169(4):2180-8. PubMed ID: 12165548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.
    Zheng P; Wu Y; Guo Y; Lee C; Liu Y
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6284-9. PubMed ID: 9600957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86].
    Nakajima A; Azuma M
    Nihon Rinsho; 1997 Jun; 55(6):1419-24. PubMed ID: 9200926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of costimulation in the induction of the IL-12/IL-12 receptor pathway and the development of autoimmunity.
    Chang JT; Segal BM; Shevach EM
    J Immunol; 2000 Jan; 164(1):100-6. PubMed ID: 10604999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
    Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
    J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD28 function: a balance of costimulatory and regulatory signals.
    Bour-Jordan H; Blueston JA
    J Clin Immunol; 2002 Jan; 22(1):1-7. PubMed ID: 11958588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.